Our data indicate that obesity, even without manifest insulin resistance, predisposes to enhanced atherosclerosis and increased oxidative stress, in which chemerin functions as a potential modulator of inflammation and oxidant/antioxidant status. The gene discussed is RARRES2; the disease is obesity disorder.